Akhilesh Pandey, M.D., Ph.D.

The purpose of this study is to develop and optimization of new technologies and protocols is a critical part of what is done in the Proteomics Core.

The purpose of this study is to be able to provide tissues that could be matched to specific types of tissue being studied for optimization and normalization, without having to use clinically relevant tissue. 

The purpose of this study is to validate recently identified urine biomarkers for urinary tract infection (UTI), including to calculate the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy in emergency department patients.

The purpose of this study is to generate expanded antigen-specific T-cell populations from healthy donor peripheral blood mononuclear cells (PBMCs) to serve as functional models of HLA-restricted immune recognition.

The purpose of this study is to generate lymphoblastoid cell lines (LCLs) from whole blood or peripheral blood mononuclear cells (PBMCs) to serve as models of diseases or as controls.

The purpose of this study is to obtain retrospective and prospective samples from subjects presented at Mayo Clinic and at outside Mayo Clinic that can be used in assay development of various types of disorders.

The purpose of this study is to validate recently identified urine biomarkers for urinary tract infection (UTI), including to calculate the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy in emergency department patients.